Global Hereditary Angioedema Market Forecast 2018-2028 - Visiongain Report

Friday, June 8, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, June 8, 2018 /PRNewswire/ --

C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor

Antagonist, Kallikrein Inhibitor (Kalbitor), Cinryze, Berinert, Ruconest, Intravenous, Subcutaneous Injection, Oral, Hospital Pharmacies, Retail Pharmacies

The global hereditary angioedema market is expected to grow at a CAGR of 8.8% in the first

half of the forecast period. In 2017, the C1 Esterase Inhibitor segment held 42% of this market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 232-page report you will receive 82 tables and 130 figures- all unavailable elsewhere.

The 232-page report provides clear detailed insight into the global hereditary angioedema market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Hereditary Angioedema Market Forecast from 2018-2028

 This report also breaks down the revenue forecast for the global hereditary angioedema market by drug class: • C1 Esterase Inhibitor: Cinryze, Berinert, Ruconest • Selective Bradykinin B2 Receptor Antagonist • Kallikrein Inhibitor (Kalbitor)

This report also provides a market attractiveness index by drug class.

 This report also breaks down the revenue forecast for the global hereditary angioedema market by route of administration: • Intravenous • Subcutaneous Injection • Oral

This report also provides a market attractiveness index by route of administration.

 This report also breaks down the revenue forecast for the global hereditary angioedema market by distribution channel: • Hospital Pharmacies • Retail Pharmacies

This report also provides a market attractiveness index by distribution channel

 This report provides individual revenue forecasts to 2028 for these regional and national markets: North America: The U.S., Canada Latin America: Brazil, Mexico, Rest of Latin America Europe: U.K., Germany, Spain, France, Italy, Russia, Rest of Europe Asia-Pacific: China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia-Pacific Middle East: GCC Countries, Israel, Rest of Middle East Africa: South Africa, Central Africa, North Africa

This report also provides a market attractiveness index by region

The forecast for each regional market is further broken down by drug class, product, route of administration and distribution channel

This report provides a market attractiveness index by drug class, product, route of administration and distribution channel for each regional market

• Our study discusses the selected leading companies that are the major players in the global hereditary angioedema industry: • BioCryst Pharmaceuticals, Inc. • CSL Limited • iBio, Inc. • Ionis Pharmaceuticals, Inc. • Pharming Group NV • Santarus, Inc. • Shire PLC

• This report discusses factors that drive and restrain the market, as well as trends and opportunities.

Visiongain's study is intended for anyone requiring commercial analyses for the global hereditary angioedema market. You find data, trends and predictions.

Buy our report today Global Hereditary Angioedema Market Forecast 2018-2028: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor (Kalbitor), Cinryze. Berinert, Ruconest, Intravenous, Subcutaneous Injection, Oral, Hospital Pharmacies, Retail Pharmacies.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website : https://www.visiongain.com/Report/2203/Global-Hereditary-Angioedema-Market-Forecast-2018-2028

Companies Listed 

AmeriCare BioCryst Pharmaceuticals, Inc Clinigen Group plc CSL Behring CSL Intellectual Property CSL Limited Dyax Corp. Fiocruz HAEi International Patient Organization iBio, Inc. iBio, Inc. Idera Pharmaceuticals Inceptua Medicines Access Ionis Pharmaceuticals, Inc. Pharming Group NV Prime Therapeutics LLC Salix Pharmaceuticals, Inc. Salix Pharmaceuticals, Ltd. Sanquin Blood Supply Santarus, Inc. Seqirus Shire plc United States of America US Hereditary Angioedema Association Valeant Pharmaceuticals International, Inc. ViroPharma Inc. World Allergy Organization

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store